Picture of Peoplebio logo

304840 Peoplebio Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Peoplebio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4,942-15,003-17,382-12,173-16,939
Depreciation
Amortisation
Non-Cash Items-1,8033,6412,6411,1949,133
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-822-3,894-3,106-1,624877
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-6,833-13,975-16,282-10,911-5,183
Capital Expenditures-1,390-1,340-760-115-324
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2,578-10,2022,077-5595,678
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3,968-11,5421,316-6745,354
Financing Cash Flow Items692-1.75-5440
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities43,3513502,01412,156-1,353
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash32,550-25,166-12,952571-1,182